Based on your results, your provider can use their clinical judgment to adjust your dose or recommend lifestyle changes
People with conditions such as Lebers disease, cobalt allergies, or known sensitivity to vitamin B12 should not receive these injections
Your safety is the top priority
Our results are the first to suggest that GLP-1 analogs are effective in patients with MC4R pathway deficiency, as evidenced by the observed improvements in body weight, food intake, and metabolic parameters
Reducing the temperature reversibly inhibited it, but phloretin did not
Limited preclinical and clinical data suggest that GLP-1 receptor agonists might modestly influence cortisol metabolism or HPA axis function in certain contexts, but findings have been inconsistent and not practice-changing